The presence of endotoxins in preparations of recombinantly produced therapeutic proteins poses serious problems for patients. Endotoxins can cause fever, respiratory distress syndromes, intravascular coagulation or endotoxic shock. A number of methods have been devised to remove endotoxins from protein preparations, using separation procedures based on molecular mass or charge properties. Most of the methods are limited in their endotoxin removal capacities and lack general applicability. We are describing a biotechnological approach for endotoxin removal. This strategy exploits the observation that endotoxins form micelles which expose negative charges on their surface leading to preferential binding of endotoxins to cationic surfaces, allowing the separation from their resident protein. Endotoxins exhibit high affinity to stretches of histidines, which are widely used tools to facilitate the purification of recombinant proteins. They bind to nickel ions and are the basis for protein purification from cellular extracts by immobilized metal affinity chromatography. We show that the thrombin mediated cleavage of two histidine-tags from the purified recombinant protein and the adsorption of these histidine-tags and their associated endotoxins to a nickel affinity column, results in an appreciable depletion of the endotoxins in the purified protein fraction.